Clinical Trial Update: A Study to Investigate the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution in Children and Adults With Epileptic Encephalopathy Including Dravet Syndrome and Lennox-Gastaut Syndrome [Phase 3]

View source ↗

Summary

Phase 3 study update reporting long-term safety data for ZX008 (fenfluramine hydrochloride) oral solution in children and adults with epileptic encephalopathy, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dravet Syndrome
• Epileptic Encephalopathy
• Lennox-gastaut Syndrome

Drugs mentioned

• ZX008 (fenfluramine hydrochloride)

Snippet

Sponsor: Zogenix, Inc. | Conditions: Dravet Syndrome, Lennox Gastaut Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2025-11-17